ALS drug gets rare second review

Matthew Perrone, AP: September 7, 2022 (This AP article was published in numerous newspapers and media outlets across the country) A closely watched experimental drug for Lou Gehrig’s disease got an unusual second look from U.S. regulators on Wednesday, following intense pressure to approve the treatment for those with the fatal illness. Patients and their […]

Read More »

Letter to the Editor: Asphalt playgrounds are bad for kids. So is artificial grass

Los Angeles Times and Yahoo News, September 7, 2022 To the editor: It’s frightening that L.A. schoolchildren are playing on sizzling asphalt, but the commentary and reporting on it miss an important part of the story. Years of research show that the school playground surfaces that are even hotter than pavement are made from artificial turf or colorful rubber. On […]

Read More »

Trump Covid Report Stirs Calls for FDA to Rebuild Public Trust

Bloomberg Law, August, 26, 2022 A House report detailing coordinated attempts by Trump White House officials to influence the FDA’s pandemic response underscores the need for more transparency at an agency that’s facing historically low public trust, health policy analysts say. The House Select Subcommittee on the Coronavirus Crisis said this week that advisers to former President Donald […]

Read More »